Felix H. Salazar

Palo Alto University — United States

Medicine · Health Sciences

21h-index3.8kcitations23works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hepatitis B Virus Studies(12), RNA Interference and Gene Delivery(11), Herpesvirus Infections and Treatments(7), Immunotherapy and Immune Responses(6), Hepatitis C virus research(3)

Publications23 total

Inhibition of hepatitis B virus replication in vivo using lipoplexes containing altritol-modified antiviral siRNAs
Artificial DNA PNA & XNA·2010· 37 citedOpen Access
DODAG; a versatile new cationic lipid that mediates efficient delivery of pDNA and siRNA
Journal of Controlled Release·2009· 99 cited
Controlling HBV Replication <i>in Vivo</i> by Intravenous Administration of Triggered PEGylated siRNA-Nanoparticles
Molecular Pharmaceutics·2009· 123 cited
Efficient Inhibition of Hepatitis B Virus Replication <i>In Vivo</i> , Using Polyethylene Glycol-Modified Adenovirus Vectors
Human Gene Therapy·2008· 38 cited
EFFICIENT INHIBITION OF HEPATITIS B VIRUS REPLICATION IN VIVO USING PEG-MODIFIED ADENOVIRUS VECTORS
Human Gene Therapy·2008· 15 cited
Exploring gene‐deleted adenoviral vectors for delivery of short hairpin RNAs and reduction of hepatitis B virus infection in mice
The Journal of Gene Medicine·2008· 27 citedOpen Access
Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways
Nature·2006· 1.7k cited
Effective Inhibition of HBV Replication in Vivo by Anti-HBx Short Hairpin RNAs
Molecular Therapy·2005· 109 citedOpen Access
In vivo antiviral efficacy of prenylation inhibitors against hepatitis delta virus
Journal of Clinical Investigation·2003· 192 cited
A transgenic mouse lineage useful for testing antivirals targeting hepatitis B virus
Elsevier eBooks·2003· 31 cited
Potent Efficacy of Entecavir (BMS-200475) in a Duck Model of Hepatitis B Virus Replication
Antimicrobial Agents and Chemotherapy·2002· 80 citedOpen Access
Molecular cloning, genomic characterization and expression of novel human α<sub>1A</sub>‐adrenoceptor isoforms
FEBS Letters·1998· 80 citedOpen Access
The pharmacology and distribution of human 5‐hydroxytryptamine<sub>2B</sub> (5‐HT<sub>2b</sub>) receptor gene products: comparison with 5‐HT<sub>2a</sub> and 5‐HT<sub>2c</sub> receptors
British Journal of Pharmacology·1995· 301 citedOpen Access
ACUTE HUMAN IMMUNODEFICIENCY VIRUS INFECTION
Transplantation·1989· 26 cited
The gag gene products of human immunodeficiency virus type 1: alignment within the gag open reading frame, identification of posttranslational modifications, and evidence for alternative gag precursors
Journal of Virology·1988· 308 citedOpen Access
Expression of K99 adhesion antigen controlled by the Escherichia coli tryptophan operon promoter
Infection and Immunity·1988· 9 citedOpen Access
Purification and structural characterization of the putative gag-pol protease of human immunodeficiency virus
Journal of Virology·1988· 73 citedOpen Access
Hepatocellular carcinoma in ground squirrels persistently infected with ground squirrel hepatitis virus.
Proceedings of the National Academy of Sciences·1986· 128 citedOpen Access
Ground Squirrel Hepatitis Virus Infection
Hepatology·1983· 45 cited
Host Susceptibility to endogenous viruses: defective, glycoprotein-expressing proviruses interfere with infections
Journal of Virology·1981· 163 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Patricia L. Marion(15), Carol Crowther(6), Patrick Arbuthnot(6), Hardy Chan(5), William H. Robinson(4), Abdullah Ely(4), Sergio Carmona(3), Mark A. Kay(2), R J Mervis(2), Nafees Ahmad(2), Erik P. Lillehoj(2), Michael G. Raum(2), Sundararajan Venkatesan(2), Chinh Bach(2), Richard M. Eglen(2), Bruno B. Bordier(2), Susan M. Astrin(2), J. J. Alexander(2), S S Knight(2), Hans Pópper(2)